Figure 2
From: High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
(A) Mesothelin mRNA expression levels between different stages of ovarian carcinoma. (B) The expression levels of chemosensitive and chemoresistant groups in 139 ovarian cancer patients with optimal (n=78) and suboptimal (n=61) debulking surgery. (C) Mesothelin mRNA expression levels in ovarian cancer patients with various progression-free intervals.
